---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-040182"
form_type: "8-K/A"
ticker: "IDXG"
cik: "0001054102"
company_name: "INTERPACE BIOSCIENCES, INC."
filed_at: "2026-08-26T14:45:11+00:00"
generated_at: "2026-08-26T14:46:14.204458+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Interpace Biosciences stockholders approve 2026 equity incentive plan and ESPP

## Summary
- Stockholders approved 2026 Equity Incentive Plan and 2026 ESPP at Aug 20, 2026 annual meeting.
- New plans replace 2019 Equity Incentive Plan and 2019 ESPP; no further grants or purchases under old plans.
- Material terms previously disclosed in proxy statement filed July 7, 2026.

## SEC filing metadata
- accession: 0001493152-26-040182
- form_type: 8-K/A
- ticker: IDXG
- cik: 0001054102
- company_name: INTERPACE BIOSCIENCES, INC.
- filed_at: 2026-08-26T14:45:11+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1054102/000149315226040182/0001493152-26-040182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1054102/000149315226040182/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-040182
- JSON: https://secwatch.observer/filing/0001493152-26-040182.json
- Plain text: https://secwatch.observer/filing/0001493152-26-040182.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.